Inhibition of interleukin-1β-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: Cooperation between PPARβ and the proto-oncogene BCL-6

Molecular and Cellular Biology

Volumn 27, Issue 23, 2007, Pages 8374-8387

  Ravaux, Lucas ^a   Denoyelle, Chantal ^a   Monne, Claire ^a   Limon, Isabelle ^a   Raymondjean, Michel ^a   El Hadri, Khadija ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; PROTEIN BCL 6; RETINOID X RECEPTOR ALPHA; LIGAND; MESSENGER RNA; PHOSPHOLIPASE A2 GROUP II; REPRESSOR PROTEIN; RETINOID X RECEPTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; CATTLE; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN BINDING; SMOOTH MUSCLE FIBER; WISTAR RAT;

RATTUS;

ANIMALS; CATTLE; ENZYME INDUCTION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROUP II PHOSPHOLIPASES A2; INTERLEUKIN-1BETA; LIGANDS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PPAR-BETA; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-6; RATS; RATS, WISTAR; REPRESSOR PROTEINS; RESPONSE ELEMENTS; RETINOID X RECEPTORS; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE DELETION;

EID: 36849000746     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00623-07     Document Type: Article

References (44)

1. Ahmad, K. F., A. Melnick, S. Lax, D. Bouchard, J. Liu, C. L. Kiang, S. Mayer, S. Takahashi, J. D. Licht, and G. G. Prive. 2003. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Mol. Cell 12:1551-1564.
2. Antonio, V., A. Brouillet, B. Janvier, C. Monne, G. Bereziat, M. Andreani, and M. Raymondjean. 2002. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors. Biochem. J. 368:415-424.
3. Antonio, V., B. Janvier, A. Brouillet, M. Andreani, and M. Raymondjean. 2003. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem. J. 376:351-360.
4. Barak, Y., D. Liao, W. He, E. S. Ong, M. C. Nelson, J. M. Olefsky, R. Boland, and R. M. Evans. 2002. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA 99:303-308.
5. Barish, G. D., V. A. Narkar, and R. M. Evans. 2006. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Investig. 116:590-597.
6. Berry, E. B., J. A. Keelan, R. J. Helliwell, R. S. Gilmour, and M. D. Mitchell. 2005. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B. Mol. Pharmacol. 68:169-178.
7. Brown, J. D., and J. Plutzky. 2007. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115:518-533.
8. Castrillo, A., and P. Tontonoz. 2004. PPARs in atherosclerosis: the clot thickens. J. Clin. Investig. 114:1538-1540.
9. Cheng, L., G. Ding, Q. Qin, Y. Huang, W. Lewis, N. He, R. M. Evans, M. D. Schneider, F. A. Brako, Y. Xiao, Y. E. Chen, and Q. Yang. 2004. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10:1245-1250.
10. Cipollone, F., C. Prontera, B. Pini, M. Marini, M. Fazia, D. De Cesare, A. Iezzi, S. Ucchino, G. Boccoli, V. Saba, F. Chiarelli, F. Cuccurullo, and A. Mezzetti. 2001. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104:921-927.
11. Clément, N., M. Glorian, M. Raymondjean, M. Andreani, and I. Limon. 2006. PGE2 amplifies the effects of IL-1beta on vascular smooth muscle cell de-differentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8. J. Cell. Physiol. 208:495-505.
12. Dent, A. L., F. H. Vasanwala, and L. M. Toney. 2002. Regulation of gene expression by the proto-oncogene BCL-6. Crit. Rev. Oncol. Hematol. 41:1-9.
13. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. 1996. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384:39-43.
14. Diep, Q. N., R. M. Touyz, and E. L. Schiffrin. 2000. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 36:851-855.
15. Elbashir, S. M., J. Martinez, A. Patkaniowska, W. Lendeckel, and T. Tuschl. 2001. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20:6877-6888.
16. François, M., P. Richette, L. Tsagris, M. Raymondjean, M. C. Fulchignoni-Lataud, C. Forest, J. F. Savouret, and M. T. Corvol. 2004. Peroxisome proliferator-activated receptor-gamma down-regulates chondrocyte matrix metalloproteinase-1 via a novel composite element. J. Biol. Chem. 279:28411-28418.
17. Hajjar, D. P., and K. B. Pomerantz. 1992. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J. 6:2933-2941.
18. Hurt-Camejo, E., S. Andersen, R. Standal, B. Rosengren, P. Sartipy, E. Stadberg, and B. Johansen. 1997. Localization of nonpancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17:300-309.
19. Ivandic, B., L. W. Castellani, X. P. Wang, J. H. Qiao, M. Mehrabian, M. Navab, A. M. Fogelman, D. S. Grass, M. E. Swanson, M. C. de Beer, F. de Beer, and A. J. Lusis. 1999. Role of group II secretory phospholipase A2 in atherosclerosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 19:1284-1290.
20. Jacques, C., G. Bereziat, L. Humbert, J. L. Olivier, M. T. Corvol, J. Masliah, and F. Berenbaum. 1997. Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes. J. Clin. Investig. 99:1864-1872.
21. Jaross, W., R. Eckey, and M. Menschikowski. 2002. Biological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesis. Eur. J. Clin. Investig. 32:383-393.
22. Jaulmes, A., B. Janvier, M. Andreani, and M. Raymondjean. 2005. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25:1161-1167.
23. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
24. Kharroubi, I., C. H. Lee, P. Hekerman, M. I. Darville, R. M. Evans, D. L. Eizirik, and M. Cnop. 2006. BCL-6: a possible missing link for anti-inflammatory PPAR-delta signalling in pancreatic beta cells. Diabetologia 49:2350-2358.
25. Lee, C. H., A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, R. M. Evans, and L. K. Curtiss. 2003. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302:453-457.
26. Lusis, A. J. 2000. Atherosclerosis. Nature 407:233-241.
27. Marx, N., H. Duez, J. C. Fruchart, and B. Staels. 2004. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94:1168-1178.
28. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:32783-32792.
29. Oliver, W. R., Jr., J. L. Shenk, M. R. Snaith, C. S. Russell, K. D. Plunket, N. L. Bodkin, M. C. Lewis, D. A. Winegar, M. L. Sznaidman, M. H. Lambert, H. E. Xu, D. D. Sternbach, S. A. Kliewer, B. C. Hansen, and T. M. Willson. 2001. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc. Natl. Acad. Sci. USA 98:5306-5311.
30. Planavila, A., R. Rodriguez-Calvo, M. Jove, L. Michalik, W. Wahli, J. C. Laguna, and M. Vazquez-Carrera. 2005. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc. Res. 65:832-841.
31. Ricote, M., J. Huang, L. Fajas, A. Li, J. Welch, J. Najib, J. L. Witztum, J. Auwerx, W. Palinski, and C. K. Glass. 1998. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA 95:7614-7619.
32. Scholz-Pedretti, K., A. Gans, K. F. Beck, J. Pfeilschifter, and M. Kaszkin. 2002. Potentiation of TNF-alpha-stimulated group HA phospholipase A(2) expression by peroxisome proliferator-activated receptor alpha activators in rat mesangial cells. J. Am. Soc. Nephrol. 13:611-620.
33. Seimandi, M., G. Lemaire, A. Pillon, A. Perrin, I. Carlavan, J. J. Voegel, F. Vignon, J. C. Nicolas, and P. Balaguer. 2005. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands. Anal. Biochem. 344:8-15.
34. Staels, B., W. Koenig, A. Habib, R. Merval, M. Lebret, I. P. Torra, P. Delerive, A. Fadel, G. Chinetti, J. C. Fruchart, J. Najib, J. Maclouf, and A. Tedgui. 1998. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393:790-793.
35. Takeda, N., M. Arima, N. Tsuruoka, S. Okada, M. Hatano, A. Sakamoto, Y. Kohno, and T. Tokuhisa. 2003. Bcl6 is a transcriptional repressor for the IL-18 gene. J. Immunol. 171:426-431.
36. Tanaka, T., J. Yamamoto, S. Iwasaki, H. Asaba, H. Hamura, Y. Ikeda, M. Watanabe, K. Magoori, R. X. Ioka, K. Tachibana, Y. Watanabe, Y. Uchiyama, K. Sumi, H. Iguchi, S. Ito, T. Doi, T. Hamakubo, M. Naito, J. Auwerx, M. Yanagisawa, T. Kodama, and J. Sakai. 2003. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc. Natl. Acad. Sci. USA 100:15924-15929.
37. Tischfield, J. A. 1997. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem. 272:17247-17250.
38. Touqui, L., and M. Alaoui-El-Azher. 2001. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:739-754.
39. Tous, M., N. Ferre, A. Rull, J. Marsillach, B. Coll, C. Alonso-Villaverde, J. Camps, and J. Joven. 2006. Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem. Biophys. Res. Commun. 340:1078-1084.
40. Tunyaplin, C., A. L. Shaffer, C. D. Angelin-Duclos, X. Yu, L. M. Staudt, and K. L. Calame. 2004. Direct repression of prdml by Bcl-6 inhibits plasmacytic differentiation. J. Immunol. 173:1158-1165.
41. Vosper, H., L. Patel, T. L. Graham, G. A. Khoudoli, A. Hill, C. H. Macphee, I. Pinto, S. A. Smith, K. E. Suckling, C. R. Wolf, and C. N. Palmer. 2001. The peroxisome proliferator-activated receptor delta promotes lipid accumulation in human macrophages. J. Biol. Chem. 276:44258-44265.
42. Wang, Y. X., C. H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159-170.
43. Yoshida, T., T. Fukuda, M. Hatano, H. Koseki, S. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, T. Miki, S. Hirosawa, N. Miyasaka, M. Taniguchi, T. Ochiai, K. Isono, and T. Tokuhisa. 1999. The role of Bcl6 in mature cardiac myocytes. Cardiovasc. Res. 42:670-679.
44. Zhang, J., M. Fu, X. Zhu, Y. Xiao, Y. Mou, H. Zheng, M. A. Akinbami, Q. Wang, and Y. E. Chen. 2002. Peroxisome proliferator-activated receptor delta is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells. J. Biol. Chem. 277:11505-11512.